Literature DB >> 18178664

Diabetic cardiomyopathy: a controversial entity.

Theodoros D Karamitsos, Apostolos Tsapas, Jayanth R Arnold.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18178664     DOI: 10.1093/eurheartj/ehm590

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

Authors:  Anderson C Armstrong; Bharath Ambale-Venkatesh; Evrim Turkbey; Sirisha Donekal; Elzbieta Chamera; Jye-Yu Backlund; Patricia Cleary; John Lachin; David A Bluemke; João A C Lima
Journal:  Diabetes Care       Date:  2016-12-16       Impact factor: 19.112

2.  Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.

Authors:  Hong Yang; Anyun Feng; Sundong Lin; Lechu Yu; Xiufei Lin; Xiaoqing Yan; Xuemian Lu; Chi Zhang
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

3.  Ischemic Versus Non-Ischemic (Neurogenic) Myocardial Contractility Impairment in Acute Coronary Syndromes: Prevalence and Impact on Left Ventricular Systolic Function Recovery.

Authors:  Paweł Iwaszczuk; Bartosz Kołodziejczyk; Tomasz Kruczek; Leszek Drabik; Wojciech Płazak; Monika Komar; Piotr Podolec; Piotr Musiałek
Journal:  Med Sci Monit       Date:  2018-06-02

4.  Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus.

Authors:  David A McAllister; Stephanie H Read; Jan Kerssens; Shona Livingstone; Stuart McGurnaghan; Pardeep Jhund; John Petrie; Naveed Sattar; Colin Fischbacher; Soren Lund Kristensen; John McMurray; Helen M Colhoun; Sarah H Wild
Journal:  Circulation       Date:  2018-12-11       Impact factor: 29.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.